Hematologic Malignancies

Case Reports

Hemophagocytic Lymphohistiocytosis: Early Treatment Leading to an Excellent Outcome

Author:

Gerald Marín-García, MD

José María-Rios, MD

William Rodriguez-Cintrón, MD

HLH is a rare and deadly disease increasingly more present in adults, but following treatment protocol may yield favorable results.

• Read More

News

Targeted CLL treatments found effective in managing associated autoimmune cytopenias

Author:

Andrew D. Bowser

Publish date: July 15, 2021

Preexisting autoimmune cytopenias frequently improved or resolved on ibrutinib, idelalisib, or venetoclax, while...

• Read More

Conference Coverage

Experimental antibody-drug conjugate shown active against r/r DLBCL

Author:

Neil Osterweil

Publish date: June 15, 2021

The experimental antibody-drug conjugate naratuximab targets CD37, a surface marker on most B-cell lymphoma...

• Read More

Conference Coverage

GLOW: Ibrutinib+venetoclax shines in first line for CLL/SLL

Author:

Neil Osterweil

Publish date: June 14, 2021

Fixed-duration therapy with the combo was associated with high progression-free survival and undetectable...

• Read More

News

Choosing the right R-CHOP dosage for elderly patients with DLBCL

Author:

Mark S. Lesney, PhD

Publish date: June 8, 2021

Systemic review finds 80 years of age an important cutoff point for switching dosage.

• Read More

News

Patients with CLL have significantly reduced response to COVID-19 vaccine 

Author:

Mark S. Lesney

Phd

Publish date: May 16, 2021

Less than half of CLL patients had an antibody-mediated response to the Pfizer vaccine in a study.

• Read More

News

GENUINE improvements: Ublituximab plus ibrutinib for CLL

Author:

Kate O’Rourke

Publish date: April 21, 2021

Ublituximab plus ibrutinib was superior to ibrutinib alone for patients with relapsed or refractory high-risk...

• Read More

News

CLL patients: Diagnostic difficulties, treatment confusion with COVID-19

Author:

Mark S. Lesney, PhD

Publish date: April 19, 2021

The overall prevalence of CLL and COVID-19 concurrence was around 0.6%, according to the review.

• Read More

News

COVID-19 vaccine failure in patients with blood cancers

Author:

Pam Harrison

Publish date: April 14, 2021

Nearly half did not produce antibodies even though they had all received both doses of one of the new mRNA COVID...

• Read More

News

Steroids can be stopped in some older multiple myeloma patients

Author:

Roxanne Nelson, RN, BSN

Publish date: April 1, 2021

There was no difference in progression-free and overall survival between two groups, with and without steroids...

• Read More

Pages

• « first
• …
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• …
• last »